−54.6
Viridian Therapeutics, Inc.\DE
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−93.8
FY23:
−184
FY24:
−232
FY25:
−276
Change from FY21 to FY25
millions USD
FY21:
−74.3
FY22:
−115
FY23:
−94.3
FY24:
−229
FY25:
−37.6
Change from FY21 to FY25
millions USD
FY21:
125
FY22:
322
FY23:
226
FY24:
458
FY25:
427
millions USD
FY21:
−3.60
FY22:
113
FY23:
−52.8
FY24:
−3.23
FY25:
113
(positive)
Change from FY21 to FY25
millions USD
FY21:
−54.9
FY22:
−94.6
FY23:
−185
FY24:
−233
FY25:
−277
All amounts in millions USD